Incretin

A Clouded Future For Big Pharma's Blockbuster Diabetes Drugs
Seeking Alpha
Wed, 04/3/13 - 10:48 am
diabetes
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Novo Nordisk
Merck
Incretin